CE Mark and Launch for Eyenuk’s Next Generation EyeArt™ Fully Automated Diabetic Retinopathy Screening Software

New Study of 59,000 patients, presented at EASDec 2016, showed EyeArt 2.0 demonstrating 91 Percent Sensitivity and 90.8 Percent Specificity